OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells $234,026.10 in Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Squadron Capital Llc sold 10,131 shares of the business’s stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $23.10, for a total transaction of $234,026.10. Following the transaction, the insider owned 6,526,633 shares in the company, valued at approximately $150,765,222.30. This trade represents a 0.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Squadron Capital Llc also recently made the following trade(s):

• On Friday, August 28th, Squadron Capital Llc sold 326,700 shares of OrthoPediatrics stock. The shares were sold at an average price of $23.04, for a total transaction of $7,527,168.00.
• On Wednesday, August 26th, Squadron Capital Llc sold 18,000 shares of OrthoPediatrics stock. The stock was sold at an average price of $24.28, for a total value of $437,040.00.
• On Tuesday, August 25th, Squadron Capital Llc sold 16,300 shares of OrthoPediatrics stock. The stock was sold at an average price of $24.74, for a total value of $403,262.00.
• On Monday, August 24th, Squadron Capital Llc sold 4,000 shares of OrthoPediatrics stock. The shares were sold at an average price of $25.75, for a total value of $103,000.00.

OrthoPediatrics Stock Down 0.9%

OrthoPediatrics stock opened at $22.59 on Friday. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.78 and a quick ratio of 2.17. OrthoPediatrics Corp. has a 1-year low of $14.42 and a 1-year high of $26.74. The company has a market cap of $589.82 million, a PE ratio of -13.45 and a beta of 0.99. The stock’s 50 day moving average price is $21.74 and its 200 day moving average price is $18.84.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.04. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%.The firm had revenue of $70.51 million during the quarter, compared to analysts’ expectations of $68.21 million. On average, sell-side analysts predict that OrthoPediatrics Corp. will post -1.14 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently commented on KIDS. TD Cowen reissued a “buy” rating on shares of OrthoPediatrics in a report on Monday, June 15th. Piper Sandler restated an “overweight” rating and issued a $25.00 price target (up from $22.00) on shares of OrthoPediatrics in a report on Wednesday, August 5th. Needham & Company LLC lifted their price objective on OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Truist Financial set a $22.00 target price on OrthoPediatrics in a research report on Wednesday, August 5th. Finally, Weiss Ratings upgraded shares of OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 5th. Nine analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $26.44.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. acquired a new stake in shares of OrthoPediatrics during the 2nd quarter worth $24,347,000. Millennium Management LLC increased its stake in OrthoPediatrics by 48.0% during the fourth quarter. Millennium Management LLC now owns 1,396,495 shares of the company’s stock worth $24,802,000 after acquiring an additional 452,840 shares during the last quarter. AIGH Capital Management LLC purchased a new position in shares of OrthoPediatrics in the 2nd quarter worth about $5,161,000. Nantahala Capital Management LLC purchased a new position in shares of OrthoPediatrics in the 2nd quarter worth about $4,636,002. Finally, AWM Investment Company Inc. purchased a new stake in shares of OrthoPediatrics during the 2nd quarter worth about $4,537,000. Institutional investors and hedge funds own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.